Calcom Vision Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 10:33 am

Competitors of Calcom Vision Ltd

All Competitor Stocks of Calcom Vision Ltd

Quarterly Result

Last Updated: August 1, 2025, 5:45 am

Below is a detailed analysis of the quarterly data for Calcom Vision Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 60.26 Cr.. The value appears strong and on an upward trend. It has increased from 44.66 Cr. (Dec 2024) to 60.26 Cr., marking an increase of 15.60 Cr..
• For Expenses, as of Mar 2025, the value is 55.74 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 40.37 Cr. (Dec 2024) to 55.74 Cr., marking an increase of 15.37 Cr..
• For Operating Profit, as of Mar 2025, the value is 4.52 Cr.. The value appears strong and on an upward trend. It has increased from 4.29 Cr. (Dec 2024) to 4.52 Cr., marking an increase of 0.23 Cr..
• For OPM %, as of Mar 2025, the value is 7.50%. The value appears to be declining and may need further review. It has decreased from 9.61% (Dec 2024) to 7.50%, marking a decrease of 2.11%.
• For Other Income, as of Mar 2025, the value is 0.21 Cr.. The value appears strong and on an upward trend. It has increased from -1.81 Cr. (Dec 2024) to 0.21 Cr., marking an increase of 2.02 Cr..
• For Interest, as of Mar 2025, the value is 1.69 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.38 Cr. (Dec 2024) to 1.69 Cr., marking an increase of 0.31 Cr..
• For Depreciation, as of Mar 2025, the value is 1.10 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.93 Cr. (Dec 2024) to 1.10 Cr., marking an increase of 0.17 Cr..
• For Profit before tax, as of Mar 2025, the value is 1.94 Cr.. The value appears strong and on an upward trend. It has increased from 0.17 Cr. (Dec 2024) to 1.94 Cr., marking an increase of 1.77 Cr..
• For Tax %, as of Mar 2025, the value is 38.14%. The value appears to be increasing, which may not be favorable. It has increased from -82.35% (Dec 2024) to 38.14%, marking an increase of 120.49%.
• For Net Profit, as of Mar 2025, the value is 1.21 Cr.. The value appears strong and on an upward trend. It has increased from 0.31 Cr. (Dec 2024) to 1.21 Cr., marking an increase of 0.90 Cr..
• For EPS in Rs, as of Mar 2025, the value is 0.87. The value appears strong and on an upward trend. It has increased from 0.22 (Dec 2024) to 0.87, marking an increase of 0.65.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 3:43 am

Growth

Last Updated: September 5, 2025, 2:46 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Calcom Vision Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.81. This value is below the healthy minimum of 5. It has decreased from 0.97 (Mar 24) to 0.81, marking a decrease of 0.16.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.80. This value is below the healthy minimum of 5. It has decreased from 0.93 (Mar 24) to 0.80, marking a decrease of 0.13.
• For Cash EPS (Rs.), as of Mar 25, the value is 3.86. This value is within the healthy range. It has increased from 3.20 (Mar 24) to 3.86, marking an increase of 0.66.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 59.33. It has increased from 35.91 (Mar 24) to 59.33, marking an increase of 23.42.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 59.33. It has increased from 56.52 (Mar 24) to 59.33, marking an increase of 2.81.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 112.66. It has decreased from 119.05 (Mar 24) to 112.66, marking a decrease of 6.39.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 9.76. This value is within the healthy range. It has increased from 7.48 (Mar 24) to 9.76, marking an increase of 2.28.
• For PBIT / Share (Rs.), as of Mar 25, the value is 6.93. This value is within the healthy range. It has increased from 5.26 (Mar 24) to 6.93, marking an increase of 1.67.
• For PBT / Share (Rs.), as of Mar 25, the value is 1.45. This value is within the healthy range. It has decreased from 1.61 (Mar 24) to 1.45, marking a decrease of 0.16.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.03. This value is below the healthy minimum of 2. It has increased from 0.98 (Mar 24) to 1.03, marking an increase of 0.05.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 2. It has decreased from 0.95 (Mar 24) to 0.79, marking a decrease of 0.16.
• For PBDIT Margin (%), as of Mar 25, the value is 8.66. This value is below the healthy minimum of 10. It has increased from 6.28 (Mar 24) to 8.66, marking an increase of 2.38.
• For PBIT Margin (%), as of Mar 25, the value is 6.15. This value is below the healthy minimum of 10. It has increased from 4.41 (Mar 24) to 6.15, marking an increase of 1.74.
• For PBT Margin (%), as of Mar 25, the value is 1.29. This value is below the healthy minimum of 10. It has decreased from 1.34 (Mar 24) to 1.29, marking a decrease of 0.05.
• For Net Profit Margin (%), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 5. It has increased from 0.82 (Mar 24) to 0.91, marking an increase of 0.09.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.70. This value is below the healthy minimum of 8. It has decreased from 0.80 (Mar 24) to 0.70, marking a decrease of 0.10.
• For Return on Networth / Equity (%), as of Mar 25, the value is 1.34. This value is below the healthy minimum of 15. It has decreased from 2.65 (Mar 24) to 1.34, marking a decrease of 1.31.
• For Return on Capital Employeed (%), as of Mar 25, the value is 8.98. This value is below the healthy minimum of 10. It has increased from 7.27 (Mar 24) to 8.98, marking an increase of 1.71.
• For Return On Assets (%), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 5. It has decreased from 0.83 (Mar 24) to 0.59, marking a decrease of 0.24.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.26. This value is within the healthy range. It has decreased from 0.39 (Mar 24) to 0.26, marking a decrease of 0.13.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.75. This value is within the healthy range. It has decreased from 0.97 (Mar 24) to 0.75, marking a decrease of 0.22.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.92. It has decreased from 1.13 (Mar 24) to 0.92, marking a decrease of 0.21.
• For Current Ratio (X), as of Mar 25, the value is 1.27. This value is below the healthy minimum of 1.5. It has decreased from 1.55 (Mar 24) to 1.27, marking a decrease of 0.28.
• For Quick Ratio (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 0.94 (Mar 24) to 0.74, marking a decrease of 0.20.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.31. This value is below the healthy minimum of 4. It has decreased from 4.01 (Mar 24) to 3.31, marking a decrease of 0.70.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.35. This value is below the healthy minimum of 3. It has increased from 2.05 (Mar 24) to 2.35, marking an increase of 0.30.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.56. This value is below the healthy minimum of 3. It has increased from 1.27 (Mar 24) to 1.56, marking an increase of 0.29.
• For Enterprise Value (Cr.), as of Mar 25, the value is 155.39. It has decreased from 237.01 (Mar 24) to 155.39, marking a decrease of 81.62.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 1.48 (Mar 24) to 0.98, marking a decrease of 0.50.
• For EV / EBITDA (X), as of Mar 25, the value is 11.40. This value is within the healthy range. It has decreased from 23.55 (Mar 24) to 11.40, marking a decrease of 12.15.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.64. This value is below the healthy minimum of 1. It has decreased from 1.22 (Mar 24) to 0.64, marking a decrease of 0.58.
• For Price / BV (X), as of Mar 25, the value is 1.23. This value is within the healthy range. It has decreased from 4.05 (Mar 24) to 1.23, marking a decrease of 2.82.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.64. This value is below the healthy minimum of 1. It has decreased from 1.22 (Mar 24) to 0.64, marking a decrease of 0.58.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness